Simplex Trading’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.63M | Buy |
29,758
+23,689
| +390% | +$969K | ﹤0.01% | 2242 |
|
|
2026
Q1 | $202K | Sell |
6,069
-34,973
| -85% | -$1.04M | ﹤0.01% | 4286 |
|
|
2025
Q4 | $1.22M | Buy |
41,042
+24,508
| +148% | +$800K | ﹤0.01% | 2431 |
|
|
2025
Q3 | $597K | Buy |
+16,534
| New | +$545K | ﹤0.01% | 3611 |
|
|
2025
Q1 | – | Sell |
-180,098
| Closed | -$6.06M | – | 9674 |
|
|
2024
Q4 | $5.42M | Buy |
180,098
+148,339
| +467% | +$4.26M | ﹤0.01% | 1429 |
|
|
2024
Q3 | $742K | Sell |
31,759
-116,349
| -79% | -$2.54M | ﹤0.01% | 3203 |
|
|
2024
Q2 | $2.63M | Sell |
148,108
-41,741
| -22% | -$666K | ﹤0.01% | 1960 |
|
|
2024
Q1 | $2.89M | Sell |
189,849
-27,872
| -13% | -$444K | ﹤0.01% | 2066 |
|
|
2023
Q4 | $3.72M | Buy |
217,721
+173,656
| +394% | +$2.02M | ﹤0.01% | 1810 |
|
|
2023
Q3 | $368K | Buy |
44,065
+35,680
| +426% | +$497K | ﹤0.01% | 3718 |
|
|
2023
Q2 | $208K | Sell |
8,385
-62,285
| -88% | -$1.61M | ﹤0.01% | 4256 |
|
|
2023
Q1 | $1.06M | Sell |
70,670
-205,114
| -74% | -$3.12M | ﹤0.01% | 2541 |
|
|
2022
Q4 | $3.26M | Buy |
275,784
+148,756
| +117% | +$1.08M | ﹤0.01% | 1501 |
|
|
2022
Q3 | $752K | Sell |
127,028
-33,381
| -21% | -$219K | ﹤0.01% | 2988 |
|
|
2022
Q2 | $681K | Sell |
160,409
-2,490
| -2% | -$15.5K | ﹤0.01% | 3071 |
|
|
2022
Q1 | $1.55M | Buy |
162,899
+49,301
| +43% | +$571K | ﹤0.01% | 2373 |
|
|
2021
Q4 | $2.16M | Buy |
113,598
+79,651
| +235% | +$2.07M | ﹤0.01% | 1960 |
|
|
2021
Q3 | $1.37M | Sell |
33,947
-3,000
| -8% | -$92.8K | ﹤0.01% | 2654 |
|
|
2021
Q2 | $1.43M | Buy |
36,947
+28,743
| +350% | +$1.13M | ﹤0.01% | 2621 |
|
|
2021
Q1 | $0 | Sell |
8,204
-872
| -10% | -$41.9K | ﹤0.01% | 10019 |
|
|
2020
Q4 | $472K | Sell |
9,076
-37,745
| -81% | -$1.28M | ﹤0.01% | 3505 |
|
|
2020
Q3 | $1.25M | Buy |
46,821
+24,687
| +112% | +$568K | ﹤0.01% | 1982 |
|
|
2020
Q2 | $431K | Buy |
22,134
+15,877
| +254% | +$256K | ﹤0.01% | 3089 |
|
|
2020
Q1 | $61K | Sell |
6,257
-56,842
| -90% | -$718K | ﹤0.01% | 4933 |
|
|
2019
Q4 | $700K | Buy |
63,099
+36,606
| +138% | +$278K | ﹤0.01% | 2405 |
|
|
2019
Q3 | $148K | Buy |
+26,493
| New | +$185K | ﹤0.01% | 3886 |
|
|
2019
Q2 | – | Sell |
-26,146
| Closed | -$198K | – | 7779 |
|
|
2019
Q1 | $210K | Sell |
26,146
-11,512
| -31% | -$62.2K | ﹤0.01% | 3560 |
|
|
2018
Q4 | $154K | Buy |
+37,658
| New | +$187K | ﹤0.01% | 3433 |
|
|
2018
Q3 | – | Sell |
-57,018
| Closed | -$651K | – | 8051 |
|
|
2018
Q2 | $749K | Buy |
+57,018
| New | +$784K | ﹤0.01% | 2050 |
|
|
2018
Q1 | – | Sell |
-45,348
| Closed | -$580K | – | 6863 |
|
|
2017
Q4 | $371K | Sell |
45,348
-9,953
| -18% | -$87K | 0.02% | 874 |
|
|
2017
Q3 | $655K | Buy |
55,301
+34,535
| +166% | +$393K | 0.03% | 539 |
|
|
2017
Q2 | $208K | Sell |
20,766
-89,624
| -81% | -$1M | 0.01% | 1171 |
|
|
2017
Q1 | $1.29M | Buy |
+110,390
| New | +$792K | 0.06% | 307 |
|
|
2016
Q4 | – | Sell |
-3,178
| Closed | -$18.6K | – | 6517 |
|
|
2016
Q3 | $24K | Buy |
3,178
+1,028
| +48% | +$6.61K | ﹤0.01% | 2806 |
|
|
2016
Q2 | $13K | Sell |
2,150
-1,593
| -43% | -$12.9K | ﹤0.01% | 3348 |
|
|
2016
Q1 | $31K | Sell |
3,743
-5,517
| -60% | -$48.3K | ﹤0.01% | 2406 |
|
|
2015
Q4 | $110K | Buy |
9,260
+7,088
| +326% | +$89.5K | 0.01% | 1278 |
|
|
2015
Q3 | $21K | Buy |
+2,172
| New | +$32.4K | ﹤0.01% | 2751 |
|
|
2015
Q1 | – | Sell |
-8,776
| Closed | -$133K | – | 5580 |
|
|
2014
Q4 | $139K | Buy |
+8,776
| New | +$114K | 0.02% | 758 |
|
Other funds holding TGTX
SCM
CAM
Simplex Trading's TGTX Position: Q2 2026 in Review
Simplex Trading increased its TG Therapeutics (TGTX) stake by 390% in Q2 2026, buying an estimated $969K and bringing the position to 29,758 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2242.
Simplex Trading first reported a position in TGTX in Q4 2014 and has held it in 39 quarters since. The position peaked at $5.42M in Q4 2024. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Simplex Trading held 29,758 shares of TG Therapeutics worth $1.63M as of Q2 2026.
- Simplex Trading bought 23,689 TG Therapeutics shares in Q2 2026, an estimated $969K.
- TG Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #2242 holding.
- Simplex Trading first reported a position in TG Therapeutics in Q4 2014 and has held it in 39 quarters since.
- Simplex Trading's TG Therapeutics position peaked at $5.42M in Q4 2024.
- 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.